Related Experiment Video
Updated: Jun 16, 2026

Measurements of Physiological Stress Responses in C. Elegans
Published on: May 21, 2020
SMAR1 regulates free radical stress through modulation of AKR1a4 enzyme activity
Sandeep Singh1, Kadreppa Sreenath, Lakshminarasimhan Pavithra
1National Centre for Cell Science, Pune University Campus, Ganeshkhind, Pune 411007, India.
Abstract:
Tumor suppressor SMAR1 is known to be involved in regulation of cell cycle and apoptotic genes transcription. It also directly interacts and stabilizes p53 through phosphorylation at serine-15 residue. Although the functions of SMAR1 are mainly restricted to the nucleus, we report its novel function with the cytoplasm. We show that SMAR1 directly interacts and inhibits AKR1a4 enzyme activity. Interestingly, AKR1a4 enzyme activity is elevated in higher grades of breast cancer where SMAR1 expression is drastically downregulated. Higher AKR1a4 activity protects the cancer cells from anticancer drugs and free radical stress. Through increased metabolism, ARK1a4 helps fulfilling higher energy needs required by cancer cell. The present study delineates yet another facet of tumor suppressor activity of SMAR1 in the cytoplasm. We also depict that upon stress, ATM kinase leads to dissociation of SMAR1-AKR1a4 complex through nuclear translocation of SMAR1 causing elevated AKR1a4 activity. Nuclear SMAR1 causes cell cycle arrest giving ample time for DNA damage repair, while AKR1a4 scavenges the excess free radicals which may further cause DNA damage. Thus, we propose a novel mechanism of regulation of oxidative stress by ATM through modulation of SMAR1-AKR1a4 complex. Further, we show that a small peptide derived from SMAR1 induces free radical stress by inhibiting AKR1a4 enzyme activity, which can be a potential anticancer therapeutic agent.
Insights
Tumor suppressor SMAR1 has a novel cytoplasmic role inhibiting AKR1a4 enzyme activity, crucial for breast cancer progression and drug resistance. This interaction offers a new therapeutic target for cancer treatment.
Area of Science:
- Molecular Biology
- Cancer Research
- Biochemistry
Background:
- SMAR1 (Swi/Snf-related matrix-associated actin-dependent regulator of chromatin subfamily 1) is a known nuclear tumor suppressor involved in cell cycle and apoptosis.
- SMAR1 stabilizes p53, a critical tumor suppressor, through phosphorylation at serine-15 residue.
Purpose of the Study:
- To investigate the novel cytoplasmic functions of SMAR1.
- To explore the interaction between SMAR1 and AKR1a4 enzyme in breast cancer.
- To elucidate the role of this interaction in cancer progression and therapeutic resistance.
Main Methods:
- Co-immunoprecipitation assays to demonstrate SMAR1-AKR1a4 interaction.
- Enzyme activity assays for AKR1a4.
- Western blotting to assess protein expression and phosphorylation.
- Cellular stress assays (drug and free radical stress).
- Analysis of patient tumor samples for SMAR1 and AKR1a4 levels.
Main Results:
- SMAR1 directly interacts with and inhibits the activity of AKR1a4 enzyme in the cytoplasm.
- AKR1a4 enzyme activity is elevated in high-grade breast cancers with downregulated SMAR1 expression.
- Elevated AKR1a4 activity confers resistance to anticancer drugs and oxidative stress by increasing cellular metabolism.
- ATM kinase activation under stress leads to SMAR1 nuclear translocation, dissociating it from AKR1a4 and increasing AKR1a4 activity.
- Nuclear SMAR1 promotes cell cycle arrest for DNA repair, while AKR1a4 scavenges free radicals.
Conclusions:
- SMAR1 exhibits a novel tumor-suppressive function in the cytoplasm by inhibiting AKR1a4.
- The ATM-mediated regulation of the SMAR1-AKR1a4 complex is a key mechanism in managing oxidative stress and DNA damage.
- A SMAR1-derived peptide inhibiting AKR1a4 shows potential as an anticancer therapeutic agent by inducing oxidative stress.
Related Concept Videos
Regulation of the Unfolded Protein Response
MAPK Signaling Cascades
Radical Autoxidation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Radical Reactivity: Overview